About ProTom International
ProTom designed our proprietary proton therapy technology in ways that significantly lower the capital and operating costs of proton centers and accelerate the adoption of this clinically-advanced treatment modality in the fight against cancer. Developing proton therapy technology is not only what we do, it’s all we do. Our medical device operations are headquartered in the USA — from which all of our manufacturing, development, service and proton therapy projects are all currently managed and operated.
Our company name is one of the newest to proton therapy, but our people certainly are not. ProTom’s senior leadership team has over 150 years of combined experience in healthcare, with more than 75 years of combined experience in proton therapy, having participated in the planning, development, and/or operations of 10 USA proton centers and several in Europe and Asia. Further, the combined expertise of our senior service and maintenance engineers spans over 170 years of service in the health care environment, with approximately 120 of these years related to accelerator technology. Our team has the singular focus, commitment and credentials to perform its work intelligently, efficiently and cost effectively.
Stephen L. Spotts – President and Chief Executive Officer
James P. Bennett – Executive Vice President, Finance, CFO
Nancy E. Corbett – Senior Vice President, Operations
Vahagn Nazaryan, Ph.D. – Senior Vice President, Physics and Technology
Dmitri Sivan, Ph.D. – Vice President, International and Scientific Relations
Robert Herron – Vice President, Information Technology
Sue Michaud – Vice President, Clinical Integration
Stephen Sledge – Vice President, Marketing and Business Development
Cheryl Smith – Vice President, Administration
Lauri K. Reichert – Vice President, Finance and Accounting, Controller
Daniel Raymond, Senior Director of Engineering
Aurelio Novo, Senior Project Management
Jay Flanz, Ph.D. – Technical Advisor
Robert Hamm, Ph.D.